Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Mar Drugs
2020 Aug 01;188:. doi: 10.3390/md18080405.
Show Gene links
Show Anatomy links
New Cytotoxic Cerebrosides from the Red Sea Cucumber Holothuria spinifera Supported by In-Silico Studies.
Abdelhameed RFA
,
Eltamany EE
,
Hal DM
,
Ibrahim AK
,
AboulMagd AM
,
Al-Warhi T
,
Youssif KA
,
Abd El-Kader AM
,
Hassanean HA
,
Fayez S
,
Bringmann G
,
Ahmed SA
,
Abdelmohsen UR
.
???displayArticle.abstract???
Bioactivity-guided fractionation of a methanolic extract of the Red Sea cucumber Holothuria spinifera and LC-HRESIMS-assisted dereplication resulted in the isolation of four compounds, three new cerebrosides, spiniferosides A (1), B (2), and C (3), and cholesterol sulfate (4). The chemical structures of the isolated compounds were established on the basis of their 1D NMR and HRMS spectral data. Metabolic profiling of the H. spinifera extract indicated the presence of diverse secondary metabolites, mostly hydroxy fatty acids, diterpenes, triterpenes, and cerebrosides. The isolated compounds were tested for their in vitro cytotoxicities against the breast adenocarcinoma MCF-7 cell line. Compounds 1, 2, 3, and 4 displayed promising cytotoxic activities against MCF-7 cells, with IC50 values of 13.83, 8.13, 8.27, and 35.56 µM, respectively, compared to that of the standard drug doxorubicin (IC50 8.64 µM). Additionally, docking studies were performed for compounds 1, 2, 3, and 4 to elucidate their binding interactions with the active site of the SET protein, an inhibitor of protein phosphatase 2A (PP2A), which could explain their cytotoxic activity. This study highlights the important role of these metabolites in the defense mechanism of the sea cucumber against fouling organisms and the potential uses of these active molecules in the design of new anticancer agents.
Abdelhameed,
New Cytotoxic Natural Products from the Red Sea Sponge Stylissa carteri.
2020, Pubmed
Abdelhameed,
New Cytotoxic Natural Products from the Red Sea Sponge Stylissa carteri.
2020,
Pubmed
Abdelmohsen,
Dereplication strategies for targeted isolation of new antitrypanosomal actinosporins A and B from a marine sponge associated-Actinokineospora sp. EG49.
2014,
Pubmed
Bayarkhangai,
A comprehensive and perspective view of oncoprotein SET in cancer.
2018,
Pubmed
Castellano,
On ovothiol biosynthesis and biological roles: from life in the ocean to therapeutic potential.
2018,
Pubmed
Chatterjee,
Nutrient utilization in actinomycetes. Induction of alpha-glucosidases in Streptomyces venezuelae.
1981,
Pubmed
Cristóbal,
PP2A regulates signaling through hormonal receptors in breast cancer with important therapeutic implications.
2017,
Pubmed
Duh,
New cytotoxic steroids from the soft coral Clavularia viridis.
2007,
Pubmed
Ebada,
Bioactive sesterterpenes and triterpenes from marine sponges: occurrence and pharmacological significance.
2010,
Pubmed
Elsayed,
Metabolomic profiling and biological investigation of the marine sponge-derived bacterium Rhodococcus sp. UA13.
2018,
Pubmed
Eltahawy,
Mechanism of action of antiepileptic ceramide from Red Sea soft coral Sarcophyton auritum.
2015,
Pubmed
Farokhi,
Cytotoxicity on human cancer cells of ophidiacerebrosides isolated from the African starfish Narcissia canariensis.
2010,
Pubmed
,
Echinobase
Furuya,
Sphingolipids in cancer.
2011,
Pubmed
Gallo,
Autoinhibitory sterol sulfates mediate programmed cell death in a bloom-forming marine diatom.
2017,
Pubmed
Gerdol,
The complex evolutionary history of sulfoxide synthase in ovothiol biosynthesis.
2019,
Pubmed
Gordaliza,
Cytotoxic terpene quinones from marine sponges.
2010,
Pubmed
Hayashi,
Estradiol suppresses phosphorylation of ERα serine 167 through upregulation of PP2A in breast cancer cells.
2017,
Pubmed
Holthuis,
The organizing potential of sphingolipids in intracellular membrane transport.
2001,
Pubmed
Huang,
Apoptotic sphingolipid ceramide in cancer therapy.
2011,
Pubmed
Ishibashi,
Algicidal sesquiterpene hydroquinones from the brown alga Dictyopteris undulata.
2013,
Pubmed
Janghorban,
Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer.
2014,
Pubmed
Jia,
Structure of Sphingolipids From Sea Cucumber Cucumaria frondosa and Structure-Specific Cytotoxicity Against Human HepG2 Cells.
2016,
Pubmed
,
Echinobase
Keen,
Protein phosphatase 2A regulates estrogen receptor alpha (ER) expression through modulation of ER mRNA stability.
2005,
Pubmed
Khalifa,
Marine Natural Products: A Source of Novel Anticancer Drugs.
2019,
Pubmed
Kumagai,
Antioxidants from the Brown Alga Dictyopteris undulata.
2018,
Pubmed
Liu,
Targeting SET to restore PP2A activity disrupts an oncogenic CIP2A-feedforward loop and impairs triple negative breast cancer progression.
2019,
Pubmed
Liu,
Potential of marine natural products against drug-resistant bacterial infections.
2019,
Pubmed
Longeon,
Bioactive indole derivatives from the South Pacific marine sponges Rhopaloeides odorabile and Hyrtios sp.
2011,
Pubmed
Malve,
Exploring the ocean for new drug developments: Marine pharmacology.
2016,
Pubmed
Mukhopadhyay,
Direct interaction between the inhibitor 2 and ceramide via sphingolipid-protein binding is involved in the regulation of protein phosphatase 2A activity and signaling.
2009,
Pubmed
Muto,
Relationship between the structure of SET/TAF-Ibeta/INHAT and its histone chaperone activity.
2007,
Pubmed
Nagasawa,
Potential anti-angiogenesis effects of p-terphenyl compounds from Polyozellus multiplex.
2014,
Pubmed
Nobili,
Natural compounds for cancer treatment and prevention.
2009,
Pubmed
Oku,
Tumor specific cytotoxicity of glucosylceramide.
2007,
Pubmed
Ruckhäberle,
Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer.
2008,
Pubmed
Senchenkov,
Targeting ceramide metabolism--a strategy for overcoming drug resistance.
2001,
Pubmed
Shen,
Isolation of aureol from Smenospongia sp. and cytotoxic activity of some aureol derivatives.
2006,
Pubmed
Skehan,
New colorimetric cytotoxicity assay for anticancer-drug screening.
1990,
Pubmed
Souza,
Anticancer activity of flavonoids isolated from Achyrocline satureioides in gliomas cell lines.
2018,
Pubmed
Sun,
Gracilarioside and gracilamides from the red alga Gracilaria asiatica.
2006,
Pubmed
Switzer,
Targeting SET/I(2)PP2A oncoprotein functions as a multi-pathway strategy for cancer therapy.
2011,
Pubmed
Thomford,
Chemical studies on the parasitic plant Thonningia sanguinea Vahl.
2018,
Pubmed
Tomoda,
Terpendoles, novel ACAT inhibitors produced by Albophoma yamanashiensis. III. Production, isolation and structure elucidation of new components.
1995,
Pubmed
Tsuda,
Iriomoteolides-1b and -1c, 20-membered macrolides from a marine dinoflagellate Amphidinium species.
2007,
Pubmed
Umegaki,
Bilobalide in Ginkgo biloba extract is a major substance inducing hepatic CYPs.
2007,
Pubmed
Vichai,
Sulforhodamine B colorimetric assay for cytotoxicity screening.
2006,
Pubmed
Vijayarathna,
Cytotoxicity of methanol extracts of Elaeis guineensis on MCF-7 and Vero cell lines.
2012,
Pubmed
Wang,
Structural Diversity and Biological Activities of the Cyclodipeptides from Fungi.
2017,
Pubmed
Wei,
Magnoflorine improves sensitivity to doxorubicin (DOX) of breast cancer cells via inducing apoptosis and autophagy through AKT/mTOR and p38 signaling pathways.
2020,
Pubmed
Yamada,
Constituents of holothuroidea. 10. Isolation and structure of a biologically active ganglioside molecular species from the sea cucumber Holothuria leucospilota.
2001,
Pubmed
,
Echinobase
Yamada,
Constituents of holothuroidea, 12. Isolation and structure of glucocerebrosides from the sea cucumber Holothuria pervicax.
2002,
Pubmed
,
Echinobase
Yardley,
Drug resistance and the role of combination chemotherapy in improving patient outcomes.
2013,
Pubmed
Zhang,
Paclitaxel resistance in MCF-7/PTX cells is reversed by paeonol through suppression of the SET/phosphatidylinositol 3-kinase/Akt pathway.
2015,
Pubmed
Zhao,
PP2A as the Main Node of Therapeutic Strategies and Resistance Reversal in Triple-Negative Breast Cancer.
2017,
Pubmed